Studies have shown that FUS protein aggregates are common in patients with ALS, and the conversion from liquid to solid is accelerated by inducing mutations in prion-like regions in the early stage of ALS or by increasing protein concentration. Here, FUS is linked to amyotrophic lateral sclerosis.